Reports of Serious Injuries and Disabilities with Moderna's mRNA...
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.4 Articles
4 Articles
As little as Moderna's new mRNA gene syringe against influenza is on the market, reports of serious health incidents are already appearing. Sudden walking, visual impairment, cardiac arrhythmia and circulatory breakdowns are among the reported symptoms. And this was the case with a preparation that was already noticed in the approval studies due to a significantly worse tolerability than conventional flu vaccines. The FDA nevertheless gave the g…
Moderna's mFLUSIVA flu vaccine as dangerous as their Covid shots
by Nicolas Hulscher, MPH Moderna’s newly approved mRNA flu injection, mFLUSIVA (mRNA-1010), already accumulated 78 reports in the Vaccine Adverse Event Reporting System (VAERS) through the October 30, 2026 data release. Among them are accounts of sudden inability to walk, partial vision loss, cardiac arrhythmias, fainting, and hospitalization. https://www.thefocalpoints.com/p/breaking-reports-of-serious-injuries? VAERS only captures less than 1%…
Reports of Serious Injuries and Disabilities with Moderna's mRNA...
Moderna's newly approved mRNA flu injection, mFLUSIVA (mRNA-1010), already accumulated 78 reports in the Vaccine Adverse Event Reporting System (VAERS) through the October 30, 2026 data release. Among them are accounts of sudden inability to walk, partial vision loss, cardiac arrhythmias, fainting, and hospitalization. VAERS only captures less than 1% of actual adverse events, according to the Harvard-Lazarus study. Thus, the actual number of ad…
🚨BREAKING: Reports of serious injuries and disabilities with Moderna’s new mRNA flu shot
BREAKING: Reports of serious injuries and disabilities with Moderna’s new mRNA flu shot have begun to FLOOD the CDC’s Vaccine Adverse Event Reporting System. Among them are accounts of sudden inability to walk, partial vision loss, cardiac arrhythmias, fainting, and hospitalization. This hazardous gene therapy should NEVER have been approved. VAERS only captures less than 1% of actual adverse events, according to the Harvard-Lazarus study. Our p…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
